Wird geladen...
Extensive Gray Matter Volume Reduction in Treatment-Resistant Schizophrenia
BACKGROUND: Approximately one-third of people with schizophrenia are treatment-resistant and some do not achieve remission with clozapine, the gold-standard antipsychotic medication for treatment-resistant schizophrenia. This study compared global and regional brain volumes between treatment-respond...
Gespeichert in:
| Veröffentlicht in: | Int J Neuropsychopharmacol |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Oxford University Press
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4540109/ https://ncbi.nlm.nih.gov/pubmed/25716781 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyv016 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|